Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Alopecia neoplastica is hair loss from breast cancer spreading to the scalp.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Localized breast cancer can affect skin and hair.

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Flaxseed lignans may reduce breast cancer risk in women.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Removing breast implants resolved the patient's symptoms.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

The Breast Utility Instrument was developed to assess quality of life in breast cancer patients.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Understanding breast cancer requires considering both medical advancements and social influences.

Antibodies help identify glycoproteins in normal skin and tumor cells.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Core symptoms in breast cancer chemotherapy remain stable, aiding targeted interventions.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Hair from breast cancer patients shows changes in structure and composition, and a test using these changes detected cancer but also falsely identified some healthy samples as cancerous.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

X-ray diffraction of hair might help detect breast cancer non-invasively.

GnRH treatment can reduce breast cancer cell invasion.

Zinc supplements and weaning cured a breast-fed baby's zinc deficiency caused by a gene mutation.

Xiaoaiping reduces chemotherapy side effects and improves quality of life for breast cancer patients.